S&P 500

5.431,60

-0,04%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Sharps Technology Inc (STSSW)
Sharps Technology Inc (STSSW) Notícias

STSSW

Sharps Technology (STSSW)

Sharps Technology Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:STSSW

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
14/06/2024	14:40	GlobeNewswire Inc.	Join Sharps Technology’s Exclusive Live Investor Webinar and Q&A Session on June 18	NASDAQ:STSSW	Sharps Technology Inc
13/06/2024	09:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STSSW	Sharps Technology Inc
13/06/2024	09:30	GlobeNewswire Inc.	Sharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC Facility	NASDAQ:STSSW	Sharps Technology Inc
05/06/2024	18:05	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:STSSW	Sharps Technology Inc
05/06/2024	09:30	GlobeNewswire Inc.	Sharps Technology Secures SC Asset Purchase Exclusivity with $1 Million Escrow Deposit	NASDAQ:STSSW	Sharps Technology Inc
04/06/2024	18:03	Edgar (US Regulatory)	Form 253G3 -	NASDAQ:STSSW	Sharps Technology Inc
03/06/2024	07:07	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:STSSW	Sharps Technology Inc
31/05/2024	09:30	GlobeNewswire Inc.	Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.	NASDAQ:STSSW	Sharps Technology Inc
31/05/2024	01:15	Edgar (US Regulatory)	Form QUALIF - Notice of Qualification [Regulation A]	NASDAQ:STSSW	Sharps Technology Inc
30/05/2024	11:12	Edgar (US Regulatory)	Form 1-A/A - Offering Statement [Regulation A]: [Amend]	NASDAQ:STSSW	Sharps Technology Inc
30/05/2024	09:30	GlobeNewswire Inc.	Sharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.	NASDAQ:STSSW	Sharps Technology Inc
29/05/2024	13:47	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:STSSW	Sharps Technology Inc
28/05/2024	14:00	GlobeNewswire Inc.	Sharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured Syringes	NASDAQ:STSSW	Sharps Technology Inc
21/05/2024	18:27	Edgar (US Regulatory)	Form 1-A - Offering Statement [Regulation A]	NASDAQ:STSSW	Sharps Technology Inc
14/05/2024	17:21	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:STSSW	Sharps Technology Inc
07/03/2024	10:00	GlobeNewswire Inc.	Sharps Technology and Roncadelle Operations Sign Worldwide Sales and Distribution Agreement for their Innovative Portfolio of Safe Technology Drug Delivery Systems	NASDAQ:STSSW	Sharps Technology Inc
21/02/2024	10:00	GlobeNewswire Inc.	Sharps Technology Enters Latin American Market and Receives First Orders for Securegard Disposable Smart Safety Syringes from Strategic Distribution Partner in Colombia	NASDAQ:STSSW	Sharps Technology Inc
16/02/2024	16:42	GlobeNewswire Inc.	Sharps Technology Planning To Collaborate With Roncadelle To Support Global Distribution And Sales Of High Quality, Innovative, Safer Drug Delivery Systems	NASDAQ:STSSW	Sharps Technology Inc
18/01/2024	11:00	GlobeNewswire Inc.	Sharps Technology Signs LOI with Roncadelle Operations Intended to Open Worldwide Sales and Distribution Opportunities for Safe Drug Delivery Systems	NASDAQ:STSSW	Sharps Technology Inc
29/09/2023	10:54	GlobeNewswire Inc.	Sharps Technology Announces Closing of $5.6 Million Registered Direct and Private Placement	NASDAQ:STSSW	Sharps Technology Inc
28/09/2023	11:52	GlobeNewswire Inc.	Sharps Technology Issues Letter to Shareholders Covering the Announced Asset Purchase Agreement to Acquire InjectEZ Prefillable Syringe Manufacturing Facility and the Associated $400 Million 10-Year Purchase Agreement with Nephron Pharmaceuticals	NASDAQ:STSSW	Sharps Technology Inc
27/09/2023	13:03	GlobeNewswire Inc.	UPDATE - Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules	NASDAQ:STSSW	Sharps Technology Inc
27/09/2023	10:14	GlobeNewswire Inc.	Sharps Technology Announces $5.6 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules	NASDAQ:STSSW	Sharps Technology Inc
26/09/2023	09:30	GlobeNewswire Inc.	Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over $400 Million from Nephron Pharmaceuticals	NASDAQ:STSSW	Sharps Technology Inc
12/07/2023	09:33	GlobeNewswire Inc.	Sharps Technology Appoints Industry Sales and Manufacturing Leader Ben Scheu as Senior Director of Sales	NASDAQ:STSSW	Sharps Technology Inc
06/07/2023	08:50	GlobeNewswire Inc.	Sharps Technology Provides Update on Commercialization Activities and is Highlighted in Med Tech Outlook Feature Article	NASDAQ:STSSW	Sharps Technology Inc
04/04/2023	09:00	GlobeNewswire Inc.	Sharps Technology Issues Update Letter to Shareholders from CEO Robert Hayes	NASDAQ:STSSW	Sharps Technology Inc
09/02/2023	11:21	GlobeNewswire Inc.	Sharps Technology Appoints Justin Page as Vice President of Technical Operations	NASDAQ:STSSW	Sharps Technology Inc
06/02/2023	11:02	GlobeNewswire Inc.	Sharps Technology Announces Closing of $3.8 Million Private Placement Priced At-the-Market	NASDAQ:STSSW	Sharps Technology Inc
01/02/2023	11:20	GlobeNewswire Inc.	Sharps Technology Announces Pricing of $3.8 Million Private Placement Priced at the Market	NASDAQ:STSSW	Sharps Technology Inc